Study Investigating Intranasal Medication to Prevent Postpartum Depression
This study plans to investigate if giving women an intranasal medication called dexmedetomidine before labor pain relief can help prevent postpartum depression after vaginal delivery.
Research Profile
Published: October 27, 2023
Added to SpecialCircle: June 19, 2026
Evidence Level
Clinical trialResearch Status
Early-stage researchKey takeaways
- •A clinical trial is planned to see if a nasal spray can prevent postpartum depression in women having vaginal deliveries.
- •The medication, dexmedetomidine, will be given before combined spinal-epidural labor analgesia.
- •Researchers hope this non-invasive method will reduce postpartum depression rates and improve maternal and neonatal well-being.
- •This will be a randomized, double-blind, placebo-controlled trial, which is a strong study design for testing a new treatment.
- •Recruitment for this study is not yet open and is expected to start in May 2026.
Source
Chengdu Jinjiang Maternity and Child Health Hospital · Clinical trial registry
Read the original sourcePlain-language summary
Postpartum depression (PPD) is a mental health condition that affects many mothers after childbirth, causing feelings of sadness, worthlessness, and impacting both the mother and baby. This study plans to investigate if a nasal spray containing dexmedetomidine, a medication known for its calming properties, can help prevent PPD.
Researchers want to see if giving this spray before labor pain relief can reduce the number of women who develop PPD after vaginal delivery. The goal is to potentially improve mothers' mental health and support their babies' early development.
How it works
Science explained
Dexmedetomidine (Dex) is a medication that works on specific receptors in the body, which helps to calm the nervous system. It has properties that can reduce anxiety, relieve pain, and help with relaxation. Studies suggest Dex may help by lowering stress hormones, decreasing inflammation, and increasing brain chemicals related to mood, which could collectively help lessen depressive symptoms.
Why parents may care
Postpartum depression (PPD) can deeply affect not only the mother's well-being but also her child's emotional, thinking, and social development, and can impact the important bond between mother and baby. If this study successfully identifies a way to prevent PPD, it could significantly improve a mother's mental health and, in turn, positively influence her child's early life and the family's overall stability.
Clinical trial journey
Phase
A randomized controlled trial designed to evaluate a new approach to preventing postpartum depression.
Enrollment
NOT_YET_RECRUITING
Data collection
Data will be collected at 7 and 42 days postpartum, assessing PPD incidence, sleep quality, pain relief, and adverse events.
Preliminary results
No preliminary results are available as the study has not yet started. Researchers hypothesize the medication will significantly reduce PPD incidence.
Regulatory / next steps
If successful, this research could lead to a novel and non-invasive prevention strategy for postpartum depression.
Who may be eligible
The study aims to enroll 270 women who are scheduled for a vaginal delivery and will receive combined spinal-epidural labor pain relief.
What is still unknown
While previous research has shown dexmedetomidine might help prevent PPD after C-sections, it's still unknown if it will be effective and safe for mothers undergoing vaginal delivery. The long-term effects of this intervention on both mothers and babies are also not yet fully understood.
Frequently asked questions about Other
This study will investigate if an intranasal spray called dexmedetomidine, given to mothers before labor pain relief, can lower their risk of developing postpartum depression after a vaginal delivery. It aims to find a new way to prevent this common condition.
Terminology glossary
- Intranasal
- Refers to a medication administered through the nose, often as a spray, allowing for quick absorption into the body without injections.
- Dexmedetomidine (Dex)
- A medication with calming, anxiety-reducing, and pain-relieving effects, which researchers believe might help reduce symptoms of depression by affecting certain brain chemicals.
- Postpartum Depression (PPD)
- A common and serious mental health disorder that can affect women in the weeks or months after childbirth, causing symptoms like persistent sadness, fatigue, and feelings of worthlessness.
- Combined Spinal-Epidural Labor Analgesia
- A type of pain relief commonly used during labor, involving both spinal and epidural injections to numb the lower part of the body and reduce pain during contractions.
- Randomized Controlled Trial (RCT)
- A study design where participants are randomly assigned to either receive the new treatment or a placebo, which helps researchers fairly compare outcomes and determine effectiveness.
- Edinburgh Postnatal Depression Scale (EPDS)
- A widely used questionnaire designed to screen for symptoms of depression in women during pregnancy and after childbirth.
Questions to ask your doctor or therapist
- ?What are my personal risk factors for developing postpartum depression?
- ?Are there any preventive strategies for postpartum depression that are currently recommended?
- ?What mental health resources are available for new mothers in our community?
- ?How might postpartum depression affect my baby's development?
⚕️ This research digest is for educational and community support purposes only. It is not medical advice, diagnosis, or treatment. Always speak with a qualified doctor, therapist, or medical professional before making decisions about care.
Related research
Understanding the Genetic Links in Hair Pulling and Skin Picking Disorders in Families
This genomic study explored the genetic roots of hair pulling (trichotillomania) and skin picking (excoriation disorder) in families, finding connections to genes involved in obsessive-compulsive disorder.
Establishing a UK Research Network for Eating Disorders
This project aims to create a UK-wide research network to improve the understanding and treatment of eating disorders by connecting child and adult services for better research collaboration.
Talk to parents who truly understand
SpecialCircle is a free, private community. Ask questions, share what works, and never feel alone.